Back to search results
NCT06857968

Mobile Mindfulness Training (mMT) for People in Medication Treatment of Opioid Use Disorder (MOUD)

Enrolling by Invitation
NAAges 18–65InterventionalTreatment
Amy Meadows
~60 participants
Updated 2026-06-08 on ClinicalTrials.gov
What's tested:Mobile Mindfulness Training

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Feasibility of Access
Measured over 75 days after enrollment
+1 more outcome measured

Conditions

Opioid Use Disorder

Explore related trials

Opioid Use Disorder

Where it's being run

1 sites across 1 states
Kentucky1

Study leadership

  • Amy Meadows, M.D. · PRINCIPAL_INVESTIGATOR · University of Kentucky

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Clinically diagnosed with Opioid Use Disorder (per DSM5 criteria)
Currently enrolled in treatment for Opioid Use Disorder at a clinic affiliated with UKHealthCare or University of Kentucky
On a stable dose of buprenorphine, buprenorphine/naloxone, or naloxone (i.e., at least 30 days post-induction and on a stable dose for 30 days)
Able to read and understand English
Have a history of childhood trauma as measured by the Adverse Childhood Experiences scale and/or Childhood Trauma Questionnaire.

Exclusion

Currently taking a beta-blocker, calcium-channel blocker, antiarrhythmic, corticosteroid, or immune modulator medication
Uncontrolled acute or chronic health conditions (e.g., active infections, autoimmune conditions, cancer undergoing active treatment)
Current or expected pregnancy
Current mindfulness practice (i.e., participant reports practicing mindfulness for 10 minutes or more per week)
Primary psychotic illness
Diagnosis of a disorder known to interfere with neurocognitive function (e.g., estimated full scale IQ below 70 or diagnosis of dementia)

What this trial measures

  • Feasibility of Access75 days after enrollment

    Proportion of enrolled participants who access the online mobile mindfulness training (mMT) application at least once.

  • Proportion of Acceptability75 days after enrollment

    Proportion of enrolled active condition participants who report using the online mobile mindfulness training application at least 25 times in 30 days.